chr5-814773-A-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_024786.3(ZDHHC11):āc.1169T>Cā(p.Ile390Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,547,974 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I390M) has been classified as Uncertain significance.
Frequency
Consequence
NM_024786.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZDHHC11 | NM_024786.3 | c.1169T>C | p.Ile390Thr | missense_variant | 11/13 | ENST00000283441.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZDHHC11 | ENST00000283441.13 | c.1169T>C | p.Ile390Thr | missense_variant | 11/13 | 1 | NM_024786.3 | P1 | |
ZDHHC11 | ENST00000503758.6 | n.2871T>C | non_coding_transcript_exon_variant | 10/12 | 5 | ||||
ZDHHC11 | ENST00000507800.1 | c.*791T>C | 3_prime_UTR_variant, NMD_transcript_variant | 10/12 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 25AN: 146480Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000220 AC: 47AN: 213868Hom.: 0 AF XY: 0.000275 AC XY: 32AN XY: 116234
GnomAD4 exome AF: 0.000123 AC: 172AN: 1401370Hom.: 2 Cov.: 30 AF XY: 0.000150 AC XY: 104AN XY: 694702
GnomAD4 genome AF: 0.000171 AC: 25AN: 146604Hom.: 0 Cov.: 33 AF XY: 0.000153 AC XY: 11AN XY: 71858
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at